Physician profile
Chris E Wilkinson
NPI 1396748505
$6,930.81
in general payments reported to CMS, 2019-2025
13 companies · $66.55 in 2025
The $66.55 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,292 · 2020: $166 · 2021: $1,919 · 2022: $1,421 · 2023: $65.74 · 2025: $66.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,855.17 | 2019-2022 | |
| Conformis, INC. | $1,767.18 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $605.57 | 2021 | |
| Tracpatch Health, INC | $448.12 | 2019 | |
| Heron Therapeutics, INC. | $65.74 | 2023 | Zynrelef |
| Globus Medical, INC. | $45.14 | 2025 | Senza |
| Pfizer INC. | $35.36 | 2021-2025 | |
| Orthalign INC | $31.11 | 2021 | |
| Linvatec Corporation | $22.78 | 2022 | |
| Zimmer Biomet Holdings, INC. | $17.80 | 2022 | |
| Conetic Solutions, INC. | $13.62 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $11.83 | 2022 | |
| Amgen INC. | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Wilkinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.